NeuroSense Therapeutics (NRSN) EPS (Basic) (2021 - 2024)
NeuroSense Therapeutics (NRSN) posted EPS (Basic) of $1.0 for Q4 2024, up 214.44% sequentially from -$0.87 in Q3 2024, and up 528.38% YoY from $0.16 in Q1 2024.
NeuroSense Therapeutics (NRSN) EPS (Basic) (2021 - 2024) Analysis & Trends
NeuroSense Therapeutics has reported EPS (Basic) for 4 years, with the latest figure at $1.0 in Q4 2024.
- Quarterly EPS (Basic) rose 528.38% year-over-year to $1.0 in Q4 2024, while the trailing twelve-month figure through Dec 2025 was $0.15 (down 71.76% YoY) and the FY2025 annual result came in at $0.44, down 20.45% from the prior year.
- EPS (Basic) grew to $1.0 in Q4 2024 per NRSN's latest filing, from -$0.87 in the prior quarter.
- Over five years, EPS (Basic) peaked at $2.74 in Q2 2021 and troughed at -$1353.7 in Q1 2023.
- A 4-year average of -$96.37 and a median of -$0.13 in 2023 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2023 and 2024: EPS (Basic) plunged 311197.55% in 2023, then surged 528.38% in 2024.
- Over 4 years, EPS (Basic) stood at $1.15 in 2021, then jumped by 49.18% to $1.71 in 2022, then plunged by 113.66% to -$0.23 in 2023, then soared by 528.38% to $1.0 in 2024.
- According to Business Quant data, EPS (Basic) over the past three periods registered $1.0, -$0.87, and $0.7 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | NeuroSense Therapeutics | 9.68 Mn | 9.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.00 |
| Sep 30, 2024 | -0.87 |
| Jun 30, 2024 | 0.70 |
| Mar 31, 2024 | -0.40 |
| Dec 31, 2023 | -0.23 |
| Sep 30, 2023 | -0.03 |
| Jun 30, 2023 | -0.27 |
| Mar 31, 2023 | -1,353.70 |
| Dec 31, 2022 | 1.71 |
| Sep 30, 2022 | -1.36 |
| Jun 30, 2022 | 0.79 |
| Mar 31, 2022 | -0.43 |
| Dec 31, 2021 | 1.15 |
| Jun 30, 2021 | 2.74 |